Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna(®) Test in the management of early-stage breast cancers

PURPOSE: The Prosigna(®) breast cancer prognostic gene signature assay identifies a gene-expression profile that permits the classification of tumors into subtypes and gives a score for the risk of recurrence (ROR) at 10 years. The primary objective of this multicenter study was to evaluate the impa...

Descripción completa

Detalles Bibliográficos
Autores principales: Hequet, Delphine, Callens, Céline, Gentien, David, Albaud, Benoit, Mouret-Reynier, Marie-Ange, Dubot, Coraline, Cottu, Paul, Huchon, Cyrille, Zilberman, Sonia, Berseneff, Helene, Foa, Cyril, Salmon, Rémy, Roulot, Aurélie, Lerebours, Florence, Salomon, Anne, Ghali, Nadeem, Morel, Pascale, Li, Qianyi, Cayre, Anne, Guinebretière, Jean-Marc, Hornberger, John, Penault-Llorca, Frédérique, Rouzier, Roman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646764/
https://www.ncbi.nlm.nih.gov/pubmed/29045452
http://dx.doi.org/10.1371/journal.pone.0185753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646764/
https://www.ncbi.nlm.nih.gov/pubmed/29045452
http://dx.doi.org/10.1371/journal.pone.0185753

Ejemplares similares